°ëºÏ³É¿¹ÉúËØsemisynthetic antibiotics °ë¿¹Ôhaptene
°ëÊýÖÂËÀ¼ÁÁ¿half lethal dose ; median lethal dose; LD50
ÖÆ¼Áѧtechnology of pharmaceutics ÖÆÒ©»¯Ñ§pharmaceutical chemistry
°²Î¿¼Áplacebo òüºÏ¼Áchelating agent °²È«·¶Î§safety range °²È«ÊÔÑé·¨innocuity test method ¸¨»ùprosthetic group ¸¨ÁÏexcipients
¸¨Ã¸coenzyme ¸±×÷ÓÃside effect
¸½¼Ó¼Áadditive ¸ÉÔï¼Ádesiccant;drying agent
¸ÎÊ×¹ýЧӦfirst pass effect of hepar ¸ÐÊÜÆ÷receptor
¸ßÃôÐÔhyperreactivity
¸öÌå²îÒìÐÔinpidual differences; inpidual variation
¸øÒ©·½°¸»ò¸øÒ©ËÙ¶Èdosage regimen or dose rate
¸øÒ©¼ä¸ôdosing interval ¹¤ÒµÒ©¼Áѧindustrial pharmacy
¹²¼Û¼ücovalent bond ·ÇÈ¥¼«»¯Ðͼ¡ËÉÒ©nondepolarizer
·Ö×ÓÒ©Àíѧmolecular pharmacology
·ÅÉä¶¾Àíѧradiotoxicology ·ÅÉäÒ©¼Áѧradiopharmaceutics
Ö°©ÊµÑécarcinogenic test Ö°©Îïcarcinogen
Ö»ûÊÔÑéteratogenic test Ö»ûÎïteratogen
ÖÂÃôÊÔÑésensitization test ×îСÓÐЧÁ¿minimal effective dose ×îСÖÂËÀ¼ÁÁ¿minimal lethal dose;MLD ÖÂÃô×÷ÓÃsensitization
ÖÂËÀÁ¿fatal dose; lethal dose ÖÆ¼Ápreparation
ÖÎÁƵÈЧ£¨Öµ£©therapeutic equivalence ±ä̬·´Ó¦allergy; allergic reaction
±íÃæ»îÐÔsurface activity ±íÃæÕÅÁ¦surface tension
¶ÌÆÚÖ°©ÊµÑéshort term carcinogenic test
°ëË¥ÆÚhalf-life period; half life time
±À½â¶Èdisintegration ±À½â¼Ádisintegrants µ¥¿Ë¡¿¹Ìåmonoclonal antibody µ¨¼îõ¥Ã¸cholinesterase
µÈÕÅÈÜÒºisotonic solution ±¡Ä¤ÒÂfilm-coating ±¥ºÍÈÜÒºsaturated solution ²»Á¼·´Ó¦adverse reaction ²ë¼Áliniments ôú¼Átincture
°üÒÂÆ¬coated tablet ³¤ÆÚ¶¾ÐÔʵÑélong term toxicity test
³¦¸ÎÑ»·enterohepatic circulation ³¦ÈÜ¿ØÊÍÆ¬enteric controlled release tablets
³¦ÈÜÒÂenteric coating ´¦·½prescription;recipe
µÎÍè¼Ápill µÝÖÊtransmitter
¶¨ÏòÒ©ÎïÖÆ¼Ádirected pharmaceutical preparations ³¤Ð§ÖƼÁprolonged action preparation Öж¾intoxication; poisoning ¶¾Àíѧtoxicology ¶¾ÐÔ·´Ó¦toxic response; toxic reaction
¶ÔÒòÖÎÁÆetiological treatment ¶ÔÖ¢ÖÎÁÆsymptomatic treatment
¶à¹¦ÄÜømultifunctional enzyme ¶à¼ÁÁ¿¸øÒ©multiple dose administration
¶ù²è·Ó°·catecholamine ¶þÖØ¸ÐȾsuperinfection
¹ýÂËfiltration ¹ýÃô¶¾ËØanaphylatoxin
¹ýÃôÐÔÒ©Îï·´Ó¦anaphylactic drug reaction ¹ýÑõ»¯Îïsuperoxide
º¬Á¿¾ùÔȶÈcontent uniformity ºÏ²¢ÓÃÒ©drug combination
ºÏ³ÉÒ©Îïsynthetic drugs ºÏ¼Ámixture
Ö¬ÖÊÌåliposome Ö±³¦¸øÒ©rectal administration
¼ÁÐÍdosage form ¼ÁÁ¿dosage; dose
»ù±¾Ò©Îïessential drugs ¼±ÐÔ¶¾ÐÔʵÑéacute toxicity test ¼ÁÁ¿»òŨ¶ÈµÄÒÀ´æÐÔdose or concentration dependency
»·¾³Ò©Àíѧenvironmental pharmacology ½ºÌåÈÜÒºÐÍÒ©¼Ámedical colloidal solution
ÉúÎï°ëË¥ÆÚbiological half life ÉúÎï¼îalkaloid
ÉúÎïÀûÓöÈbioavailability ÉúÎïÒ©¼Áѧbiopharmacy
ÉúÎïÖÆÆ·biological product ÉúÒ©crude drugs
ÎÈ̬ѪҩŨ¶Èsteady state plasma concentration
ÎïÀíÒ©¼Áѧphysical pharmaceutics Ò©Îïѧpharmacology; materia medica
ÎüÈë·¨inhalation ÎüÊÕËÙÂʳ£Êýabsorption rate constant
ʱ³½Ò©Àíѧchronopharmacology ʱ¼äÖÎÁÆchronotherapy
ʱ¼ä¸ÐÊÜÐÔchronosusceptability ʱЧ¹ØÏµtime-effect relationship ½ÀÓÃÆ¬chewable tablets ½Í½âglycolysis
Þ׿¹×÷ÓÃantagonism ½â¶¾×÷ÓÃdetoxication
½éÖÊmediator; transmitter; medium ¾«ÉñÒÀÀµÐÔpsychic dependence
¾çÒ©powerful drug ¾ø¶ÔÖÂËÀ¼ÁÁ¿absolute lethal dose; LD100
¹ãÆ×¿¹ÉúËØbroad-spectrum antibiotic
¿¹¶¾ËØantitoxin ¿¹¾úÆ×antibacterial spectrum
¿¹Ò©ÐÔresistance to drugs ¿ØÊÍÖÆ¼Ácontrolled release preparation
¿ÚÇ»ÄÚ¸øÒ©oral administration ¿ìËÙÄÍÊÜtachyphylaxis
À©É¢diffusion À©É¢ÏµÊýcoefficient of diffusion ÀÛ»ýÄòÅÅйÇúÏßcumulative urinary excretion curves
ÀÛ¼ÓЧӦadditive effect Àà¶¾ËØanatoxin;toxoid
Àà¹Ì´¼Í£Ò©×ÛºÏÕ÷steroid withdrawal syndrome
Á¿×ÓÒ©Àíѧquantum pharmacology µ÷¼Áѧdispensing pharmacy ÁÙ´²Ò©Àíѧclinical pharmacology ÁÙ´²Ò©Ñ§chlinical pharmacy
ÄÍÊÜÐÔtolerance ÄÍÒ©ÐÔdrug tolerance
ÄÚ¶¾ËØendotoxin Ƭ¼ÁÓ²¶Ètablet hardness
ÄÚ¶¾ËØö×ÊÔ¼Á²â¶¨·¨Limulus Amebocyte Lysate assay for endotoxin
ÄÚÏûÐýÌåmesomer Ũ¶Èconcentration
Ƥ·ô¡¢Õ³Ä¤±íÃæ¸øÒ©skin and mucocutaneous administration
ÆøÄý½ºaerogel ÆøÈܽºaerosol
ÆøÌå·ÖÎögas analysis ÆøÎí¼Áaerosol
ǰÌåÒ©Îïprodrug ÇÊÄÚ×¢Éäintrathecal injection
ÏÞÖÆÐÔ¾çÒ©restrictive holagogue Ïà¶Ô¸øÒ©¼ä¸ôrelative dosage interval
Ïà¼Ó×÷ÓÃadditive effect; addition Ïò°Ð¸øÒ©targetable drug delivery ҩЧ¶¯Á¦Ñ§pharmacodynamics Ò©Ô´ÐÔ¼²²¡drug-induced diseases
ÒÒõ£µ¨¼îÒÒõ£µ¨¼îacetylcholine ÒÒõ£µ¨¼îõ¥Ã¸acetylcholinesterase
ÒÖ¾ú»îÐÔbacteriostatic activity ÒÖ¾ú×÷ÓÃbactriostasis
Ò칹øisomerase
Ïû³ýËÙÂʳ£Êýelimination rate constant Ч¼Ûpotency
Ч¼Ûµ¥Î»potency unit Ч¼ÛÇ¿¶Èpotency
ЧӦeffect ЧӦÆ÷effector
ЧӦÎïeffector Ðͬ×÷ÓÃsynergism
ÐË·ÜÐÔexcitability Ñ¡ÔñÐÔselectivity
Ðü¸¡Òºsuspension
Ѫ¹ÜÄÚ¸øÒ©intravascular administration Ѫ¹ÜÍâ¸øÒ©extravascular administration
Ѫ½¬plasma Ѫ½¬´úÓÃÒºplasma substitute Ѫ½¬µ°°×½áºÏÂÊplasma protein binding ratio
ѪÄÔÆÁÕÏblood-cerebral barrier ѪҩŨ¶Èblood concentration
ѪÇåserum ѪҺÄý¹Ìblood coagulation ѪÈÝÁ¿À©³ä¼Áblood volume expander ÑªÒºÖÆÆ·blood products
ÑǼ±ÐÔÖж¾subacute intoxication;subacute poisoning
ÑÇÏõËáÑÎÖж¾nitrite poisoning ÑÛÓÃĤ¼Áocular inserts
Ò©¡ªÊ±°ë¶ÔÊýÇúÏßsemi-logarithmic curve of drug-time
Ò©¡ªÊ±ÇúÏßdrug-time curve Ò©·åŨ¶Èpeak concentration of drug
Ò©·åʱ¼äpeak time of drug Ò©¼ÁµÈЧÐÔpharmaceutical equivalence
Ò©¼Áѧpharmaceutics Ò©Àíѧpharmacology
Ò©ÃôÊÔÑédrug sensitive test
Ò©Îï´úлdrug metabolism Ò©Îï´úлødrug metablic enzyme
Ò©ÎïµÄÌåÄÚ¹ý³Ìintracorporal process of drugs
Ò©ÎﶯÁ¦Ñ§Ä£ÐÍpharmacokinetics model
Ò©Îï·´Ó¦drug reaction Ò©Îï·Ö²¼drug distribution
Ò©ÎïÅÅйdrug excretion Ò©ÎïÎüÊÕdrug absorption
Ò©ÎïÏ໥×÷ÓÃdrug interaction Ò©ÎïÏû³ýdrug elimination
Ò©ÎïÐî»ýdrug accumulation ȫøÓ븨»ùholonzyme and prosthetic group
È˹¤ºÏ³É¿¹Ôartificial antigen È˹¤ÃâÒßartificial immunization ÈËÖÖÒ©Àíѧethnopharmacology ÂñÖ²¼Áimplants
ÂýͨµÀslow pathway Ãô¸ÐÐÔsensitivity
ÂýÐÔ¶¾ÐÔʵÑéchronic toxicity test; long term toxicity test
øenzyme øÔproenzyme
ÃâÒßÒÖÖÆ¼Áimmunosuppressant;immuno inhibitor
ÃâÒßÔÐÔimmunogenicity ÃâÒßÔöÇ¿¼Áimmunoenhancement ¿¹Ìåantibody ¿¹ÑªÇåantiserum
¿¹Ôantigen Èܽâdissolution; dissolving
Èܾúølysozyme ÈÜѪhemolysis
ÈÜÖÊsolute ÈýôÈËáÑ»·tricarboxylic acid cycle ɱ¾ú»îÐÔbactericidal activity ɱ¾ú×÷ÓÃbactericidal effect
ÉíÌåÒÀÀµÐÔphysical dependence Éñ¾¶¾ËØneurotoxin
ÉöÉÏÏÙËØÄÜÉñ¾adrenergic nerve ÉöÉÏÏÙËØÄÜÊÜÌåadrenergic receptor ÉøÍ¸Ñ¹osmotic pressure ÈܼÁsolvent; dissolvent
ÊÕÁ²Ò©astringent ÊÖÐÔÒ©Îïchiral drug
Ê×¹ýЧӦfirst-pass effect ÊÜÌåreceptor
Ë®½â£¨×÷Óã©hydrolysis ÌÇÒìÉú×÷ÓÃgluconeogenesis

